| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $872K | +7.4% | +70.7% |
| R&D Expense | $575K | +12.1% | +1.0% |
| SG&A Expense | $1.5M | +5.5% | -30.8% |
| Operating Income | -$1.8M | -5.2% | +33.8% |
| Pre-tax Income | -$1.9M | -11.9% | -374.6% |
| Income Tax | $0 | — | — |
| Net Income | -$1.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.4M | +1739.4% | +798.3% |
| Accounts Receivable | $1.3M | +56.3% | +238.0% |
| Current Assets | $7.1M | +384.6% | +219.5% |
| Total Assets | $11.2M | +97.7% | +6.0% |
| Current Liabilities | $3.6M | +114.3% | -2.5% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.0M | -91.0% | — |
| Capital Expenditures | $39K | — | — |
| Investing Cash Flow | -$665K | — | — |
| Financing Cash Flow | $7.3M | — | — |
| Free Cash Flow | -$4.0M | — | — |
| -52.2% |
| EPS (Basic) | -$0.72 | -4.3% | -928.6% |
| EPS (Diluted) | -$0.72 | -4.3% | -928.6% |
| $1.1M |
| +1.1% |
| +11.0% |
| Total Liabilities | $5.0M | +62.8% | -0.5% |
| Stockholders' Equity | $6.1M | +147.8% | +12.1% |